Medtronic (NYSE:MDT) today announced CE mark approval and the first commercial European implants for its OmniaSecure system.

The surgical navigation and robotics system is part of the company’s push to expand its share of the $15 billion cranial and spinal technologies market.

Medtronic (NYSE:MDT) today announced data from the ALERT trial aimed at addressing health disparities in structural heart care.

Medtronic views Stealth Axis as the ‘cornerstone’ of AiBLE, the company’s surgical workflow ecosystem.

The U.S. Court of Appeals for the Ninth Circuit ruled that Medtronic can’t be sued by a man who alleged the company’s spinal cord stimulator malfunctioned, according to a document filed March 25.

The question remains: what will it take to prove that any protection device is having a meaningful impact on stroke risk?

The U.S. Court of Appeals for the Ninth Circuit ruled that Medtronic can’t be sued by a man who alleged the company’s spinal cord stimulator malfunctioned, according to a document filed March 25.

What is Deep Brain Stimulation for depression? Discover how the TRANSCEND trial at UT Southwestern is using "brain pacemakers" to treat treatment-resistant depression by targeting neural communication ...

Medtronic plc (NYSE:MDT) is included among the Dividend Kings and Aristocrats List: 32 Biggest Stocks. On March 24, Medtronic plc (NYSE:MDT) said it has entered into a distribution agreement with ...

Deep brain stimulation (DBS) has emerged as a standard of care in the treatment of Parkinson’s disease and other movement disorders, such as dystonia and ...

Exclusive agreement expands Medtronic's comprehensive pain interventions portfolio, increases treatment options for patients ...

Fox News may earn a commission if you buy through our referral links. This content was created by a team that works independently from the Fox newsroom.